He Wei-Wu
SEC insider (Form 3/4/5 filer). CIK 0001542073. Director & 10% Owner at CASI Pharmaceuticals, Inc. (CASIF). 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. Located in BEIJING.
Companies He Wei-Wu has filed insider reports for
- CASI Pharmaceuticals, Inc. (CASIF): Director, 10% Owner
He Wei-Wu
CIK: 0001542073
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CASIF
CASI Pharmaceuticals, Inc.
Director10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions